Podcasts about aids

A mile-long island in New York holds more than a million bodies. No headstones. No funerals. Just rows of pine boxes disappearing into the earth.Just off the coast of the Bronx sits Hart Island, America's largest public cemetery and the final resting place for the people society forgot. Since 1869, the island has received the unclaimed, the unidentified, the poor, and even victims of epidemics, quietly burying them in long trenches beneath the soil.In this episode, we explore the haunting history of Hart Island and the millions of lives laid to rest there from Civil War prisoners and AIDS victims to the marginalized dead of modern New York. What began as a city potter's field became a hidden archive of tragedy, inequality, and forgotten humanity. One of the most chilling chapters in American queer and urban history.Hosted by Jordi and Brad, Beers With Queers: A True Crime Podcast dives into chilling crimes, queer history, and twisted justice, all with a cold one in hand.Press play, grab a drink, and join us as we uncover the darkest corners of LGBTQ+ history. Hosted on Acast. See acast.com/privacy for more information.

In this episode: On the eve of the final day of Florida's 2026 regular session, the Republican-controlled Legislature passed bills that will throw up more bureaucratic roadblocks to voting and allow state politicians to target “domestic terrorist” groups. But they also agreed not to give billions of dollars to the biggest corporations in the country and to help thousands of Floridians at risk of losing AIDS and HIV medication. Plus: Last-day floor fights are looming between urban and rural lawmakers over growth and development. An update from Day 59 of Florida's 60-day session. Show notesThe bills discussed in today's show: House Bill 991 — Election IntegrityPassed the Senate by a 27-12 vote (vote sheet). Passed the House of Representatives by a 77-28 vote (vote sheet). Now goes to the governor.House Bill 1471 — Systems of Law and Terrorist OrganizationsPassed the House of Representatives by an 80-25 vote and now goes to the governor (vote sheet)House Bill 7031 — TaxationPassed the House of Representatives by a 109-0 vote and now goes to the governor (vote sheet)House Bill 697 — Drug Prices and CoveragePassed the House of Representatives by a 108-0 vote and now goes to the governor (vote sheet)The stories discussed in today's show: No water, no shade: How homebuilders, farming companies and construction firms got politicians to reject heat rules for outdoor workers in FloridaCorporations could get a $3.5 billion tax break in Florida unless state lawmakers step in to stop itQuestions or comments? Send ‘em to Garcia.JasonR@gmail.comListen to the show: Apple | SpotifyWatch the show: YouTube Get full access to Seeking Rents at jasongarcia.substack.com/subscribe

Send a textWhen Yvette Raphael walked into a stakeholder meeting in Kigali in 2019 and asked Gilead's lead researcher, "What are you going to do differently?", she was doing her job. As co-founder of Advocacy for Prevention of HIV in Africa and chair of the Global Community Advisory Board for the PURPOSE 1 trial, Yvette has spent decades ensuring that women most affected by HIV are not just research subjects, but architects of the science designed to protect them.In this episode, she tells the inside story of lenacapavir, Science magazine's 2024 Breakthrough of the Year, from the community trust-building that made the PURPOSE trials possible, to the moment at AIDS 2024 when results showing 100% efficacy brought a room of scientists to their feet.But Yvette is clear: a breakthrough is only a breakthrough if it reaches the people who need it. With PEPFAR funding under threat and rollout decisions being made without community voices, she pulls no punches on what accountability from science, pharma, and governments must actually look like.To support us, consider becoming a paid subscriber on Patreon or making a one-time donation via PayPal. Subscribe to our weekly newsletter: globalhealthunfiltered.comFollow us on X (@unfiltered_gh), LinkedIn, Instagram, and TikTok.

Marsh looks at the history of AIDS denialism, and its apparent burgeoning resurgence through the world's most listened to podcast. Meanwhile, Alice buys a new car that she is unable to drive.Sign up for the Skeptics with a K Patreon at https://patreon.com/skepticswithak, or to support Merseyside Skeptics as well as the podcast, donate at https://patreon.com/merseyskeptics.You can also chat with us on the Skeptics in the Pub Discord server.Mixed and edited by Morgan Clarke.

  Christina Hello, everyone, I'm Christina Darnell, the managing editor of MinistryWatch. Welcome to the MinistryWatch podcast. In today's extra episode, I talk with Warren Smith about some news items that are slightly (even significantly) outside of our normal charity and philanthropy “beat.” So, Warren, what's up first? Warren This week, I've been thinking a bit about Lonnie Frisbee, one of the more interesting and tragic figures of American Evangelicalism was Lonnie Frisbee. Christina He was a key figure in the so-called “Jesus Revolution” of the 1970s, and he helped found two church movements still around today: Calvary Chapel and Vineyard Churches. Warren That's right. He influenced John Wimber, Greg Laurie, and many others. He died this week (March 12) in 1993 of AIDS. But before he died, he had an outsized impact on the Jesus Revolution, both for good and for ill. I won't go into his biography here, but if you check out my “Signs and Wonders” column this week, I have a link to a longer story I did about him a few years ago. It will be in the show notes for today's program. To read more about Frisbee and the mark he left on American Evangelicalism, click here. Christina You've also been thinking about Kazakhstan this week. Warren Yes, it might sound strange, but I am paying attention to Kazakhstan this week. Christina That seems kind of random. Is there a reason? Warren They vote on Friday on a new constitution, the third constitution since 1993. Kazakhstan is one of the largest countries in the world by land mass. And within Kazakhstan is the largest lake in the world, the Caspian Sea, which is not a sea at all, but a massive lake the size of the state of Montana. Christina But for all its size, it has only about 20 million people. Warren A long-time Soviet satellite, it is an independent nation with a sizable Christian population – about 20 percent. However, it is a country that has a history of human rights, free speech, and civil liberties violations. Critics say the new constitution will further consolidate power with the country's chief executive. Christian ministries operating in Kazakhstan include the Kazakhstan Baptist Union, Youth for Christ, Salvation Army, Operation Mobilization, and International Fellowship of Evangelical Students. Christina Another event happening this week is a bit outside of MinistryWatch's normal coverage, but is a huge cultural event. That's the South by Southwest festival in Austin, Texas. Warren South by Southwest, commonly called “South by,” is one of the largest tech, movie, music, and culture events in the country. It regularly draws 120,000 to Austin, Texas. I covered SXSW for WORLD and was always able to find some explicitly Christian events going on. Last year, there was a significant faith component to the proceedings. Silicon Valley Christian hosted SVC at SXSW. It was the largest explicitly Christian gathering at South by this year. Last year's event included a “keynote conversation” with actor Zachary Levi, cultural conversations about Christianity in tech spaces, and music, including musicians Matt Maher and For King and Country. The details on this year's event are vague, though its Sunday worship service appears still to be on. Christian artists appearing at South by this week include Mission and Sam Llanes. Christina South by Southwest has a significant technology component. In fact, it was at South by that Twitter was first rolled out, in the early 2000s. From those beginnings, social media has gone on to take over the world in many ways. Warren That's right, but now new laws are attempting to limit social media, especially in the lives of young people. One of those new laws was recently passed in Virginia. Christina But WORLD Magazine reports that a federal judge on Feb. 27 temporarily paused enforcement of the Virginia law. Warren The law would limit minors under 16 to one hour of screen time per social media platform per day.”  The law was supported by Virginia Gov. Glenn Youngkin, the state's attorney general, and an overwhelming bipartisan majority of the Virginia legislature. Christina Nonetheless, U.S. District Judge Patricia Tolliver Giles sided with NetChoice, an industry trade group representing YouTube, Google, X, Netflix, and other platforms. Warren The judge said the law violated First Amendment free speech protections. Giles said the 2025 law “burdens more speech than necessary as it requires all persons to verify their age before accessing speech that is protected for everyone.” The state has appealed the ruling. Christina And there's more trouble in the Anglican Church in North America. Warren ACNA appointed Bishop Julian Dobbs to be its acting archbishop back in November, when Archbishop Steve Wood was credibly charged with sexual harassment of one of his employees. Now, old accusations that Dobbs misappropriated $47,862 have been raised by one of his rivals, Bishop Derek Jones. Christina Jones left ACNA a few months ago following a controversy over his leadership of the military chaplains. He has formed a new denomination called the Anglican Reformed Catholic Church. Warren Dobbs is now suing Jones for defamation. Dobbs says the disputed sum is $3,750, and the money was not misappropriated, but temporarily put into the wrong back account. The mistake was caught and quickly corrected. Former Archbishop Foley Beach backs up Dobbs' version of the story. Dobbs asked a federal court in Alabama to order Bishop Derek Jones to pay compensatory and punitive damages. Christina That brings us to the end of this week's conversation. Any final notes before we go? Warren A few. Did you know I also write fiction? I published a novel back in 2017, and I'm working on a new novel now. The Blacklist, an influential community of screenwriters and novelists, is featuring my novel-in-progress Up The American on its site this week. If you want to read the excerpt they are publishing, I'll link to it in today's show notes. I have some travel coming up in the next couple of months, and I would love to see you. I will be in Los Angeles in April and Dallas in May. I will be doing reader lunches in both cities. Let me know if you would like to join us. My email is wsmith@ministrywatch.com. Christina The producer for today's program is Jeff McIntosh. I'm Christina Darnell, with my co-host Warren Smith. Until next time, may God bless you.

Public health work can feel heavy right now.In this short reflection, Omari Richins shares a powerful lesson from the AIDS crisis: communities survived not just through protest and advocacy, but through joy and connection.This episode is about finding ways to keep showing up for public health, health equity, and our communities - even during difficult times.Omari also shares a quick update on the podcast and invites listeners to complete a short survey to help shape future episodes.TPHM Needs Survey

Friend of the show Dr. Sika Dedo joins us to talk about her research around HIV/AIDS in Senegal and the lessons we can learn from it.See omnystudio.com/listener for privacy information.

The sexual revolution didn't happen all at once, it came in throbbing waves: the Pill. Stonewall. The AIDS crisis. The Internet. Grindr. PrEP. Doxy PEP. Sniffies! We have more options than ever before and yet some still feel lonely. Swipe culture gives us abundance, but it also trains us to treat each other like custom coffee drinks. How do we build intimacy without running a background check on somebody?And why does jealousy still show up like it is paying the rent?Today, queer activist and marriage and family therapist Damon L. Jacobs joins us to unpack the great queer divide: monogamy vs. open relationships.His web series Choosing Queer Joy argues that joy isn't frivolous, it's revolutionary. But when we start talking about sex, love, and commitment the revolution can get real messy, real fast.FOLLOW US ON INSTAGRAM:★ instagram.com/faustofernos★ instagram.com/marcfelion★ instagram.com/damonljacobs

Part 3 of Deconstructing The Myth of Aids 

In this conversation, Dr. Dean Mitchell shares his journey from tennis to medicine, emphasizing the importance of understanding allergies and the immune system. He discusses his experiences during the AIDS epidemic, the role of mast cells in allergic reactions, and the impact of environmental factors like mold on health. The conversation also touches on the rising prevalence of allergies, the significance of the microbiome, and innovative desensitization techniques for managing allergies. Dr. Mitchell highlights the connection between mental health and immune function, advocating for a holistic approach to health.TakeawaysDr. Mitchell has been playing tennis since he was a teenager.The immune system plays a crucial role in health and disease.Mast cells are key players in allergic reactions.Environmental factors can significantly impact health.Mold exposure can lead to various health issues.The rise in allergies may be linked to microbiome disruption.Stress can weaken the immune system and trigger allergies.Desensitization techniques can help manage severe allergies.A diverse microbiome is essential for good health.Listening to patients is vital for effective treatment.Timeline[00:00] Introduction[02:26] Journey into Medicine and Immunology[05:57] Lessons from the AIDS Epidemic[10:23] Understanding Allergies Definitions and Differences[16:12] Environmental Factors and Mast Cell Activation[20:45] The Impact of Mold on Health[27:50] Rising Allergies Causes and Concerns[30:26] Rebuilding the Microbiome[33:53] The Role of Viruses in Immune Response[38:03] Desensitization Techniques for Allergies[47:11] Mental Health and Immune FunctionDr Dean Mitchell Podcast The Smartest Doctor in The Room https://podcasts.apple.com/au/podcast/the-smartest-doctor-in-the-room/id1612081247 Music Song: Joakim Karud - Thank You (Vlog No Copyright Music)Music provided by Vlog No Copyright Music.Video Link: https://youtu.be/o4RybjThnEo --------------------The content and information provided here is the opinion of Mihaela Raguz and is for informational purposes only. It is not intended to provide medical advice or take the place of medical advice or any current treatment you are undertaking. It is advised that you consult your doctor or health professional in relation to any health concerns you may have. Mihaela Raguz does not take responsibility for any health consequences which occur from a person viewing or reading this content. Please note if you are taking prescription do not stop your medication or start any new protocol including but not limited to supplements, diet, lifestyle changes without consulting your doctor or health professional.--------------------

This episode of The CommonHealth features a discussion of the recently published book, Deployed: A Physician on the Front Lines of Global Health, by Kevin M. De Cock.  In Deployed, De Cock details an insider's perspective confronting infectious disease crises from the AIDS pandemic to Ebola to Covid-19. He explores the intersections between medicine, global public health, and epidemiology throughout decades of public health evolution across continents and crises. De Cock draws from his experiences in diverse settings to offer practical guidance to a new generation of health leaders. 

Today, we are thrilled to kick off Carol Lynn Pearson week on Mormon Stories Podcast! Join us for the re-broadcast of two very important interviews with a one-of-a-kind Mormon woman. Then, we will close out the week by welcoming Carol Lynn Pearson back on the podcast to celebrate the release of her new book, The Diaries of Carol Lynn Pearson, where we will also be joined by the director of Signature Books, Barbara Jones Brown.Carol Lynn Pearson is the author of a 1986 memoir, Goodbye, I Love You, about the death of her gay husband from AIDS.Her musical, My Turn on Earth, is among the most successful Mormon musicals of all time.Carol Lynn is an advocate for women and LGBTQ+ Mormons. Her 2007 book, “No More Goodbyes,” tells the stories of gay Mormons (and those of other faiths), coping with family, religion, and, occasionally, suicide.Today's interview was filmed in 2010, and was originally broken into four parts and released as episodes 173-177. We have compiled them into a singular episode in order to re-introduce it to our listeners.CONTENT WARNING: This series contains discussion of suicide and suicidal ideation. Please listen responsibly.___________________YouTubeAt Mormon Stories we explore, celebrate, and challenge Mormon culture through in-depth stories told by members and former members of The Church of Jesus Christ of Latter-day Saints as well as scholars, authors, LDS apologists, and other professionals.  Our overall mission is to: 1. Facilitate informed consent amongst LDS Church members, investigators, and non-members regarding Mormon history, doctrine, and theology2. Support Mormons (and members of other high-demand religions) who are experiencing a religious faith crisis3. Promote healing, growth and community for those who choose to leave the LDS Church or other high demand religions

Lisa Petty began her dance career in 1980s New York, intoxicated by the grime and flamboyant life of the city. She witnessed countless friends lose their lives to AIDS,  and the lessons she learned in closeness have stayed with her.As a young woman, Lisa Petty was visiting her aunt in a retirement home when she started to speak to the older people there about the role of wartime dance halls in their lives.These were stories of luminous intimacy. The old men and women's faces would light up as they remembered being close enough to attractive strangers to smell them, to move together with music, and to have a few hours reprieve from the stress of war.These stories inspired Lisa's masters studies and she moved to New York to pursue a career in dance.There, she found a friend soulmate in a man called Raymond, and they lived together for several years, before and after he became sick with AIDS.After Lisa returned to Melbourne, she left her dance career behind and began working as an intimacy and movement director, helping performers to channel their character's energy and translate that into the language of touch.Further informationThis episode was produced by Alice Moldovan. Conversations' Executive Producer is Nicola Harrison. It covers topics including intimacy, touch, single mum, AIDS, New York, Kaposi sarcoma, dance, intimacy co-ordinator, movement coach, theatre.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

This week on the Queer News podcast, in top news, New York Attorney General Letitia James orders NYU Landon to resume gender-affirming care for minors. Current and past LGBTQ+ federal employees speak up about suing Trump, and Florida suddenly cuts funding for HIV and AIDS Health Care. In culture and entertainment, we uplift the 37th annual GLAAD awards.    Want to support this podcast?

***Trigger Warning - AIDS crisis, bereavement and griefWell Sh*t. It really is that simple - Episode 197 - "The importance of joy when times are tough" is now LIVE!Full Show notes: https://bit.ly/WellShitEpisodeGuideOne of the most important emotions to experience when times are challenging, is also one of the first emotions to go. Today we're talking about joy. In difficult times joy is an emotion that can feel so far away from where we are currently at. So how do we honor what is happening around us while also allowing the full spectrum of emotions that may be present? Tune into today's episode where we discuss why we resist joy, how we can begin to allow joy that is present and cultivating moments of joy that may not have seemed possible.In this episode we cover:The holiday sweater debateWhy Claire is airing on the side of ridiculous for her singing competitionThe challenge with showing and sharing joy in difficult timesResisting joy in griefAllowing and processing the full spectrum of emotionsThe difference between authentic joy and masking "joy"Processing our experiences more authentically and becoming more resourced in terms of our emotionsShifting ourselves out of the direction of "this is what it's meant to look like"Creating a space for all the emotions to be presentRecognizing the potential for joyThe steps to cultivating joyCreating small moments of joyChecking in with where you're at and what will truly bring you joyEpisode References:The episode on resisting joy - Episode 133 - Why we sometimes resist joyThe negative emotions episode - Episode 33 - Why there's no such thing as negative emotionsThe episode where Serena talks about getting punchy - Episode 118 - I feel like I want to be angry but I don't know whyNotes:Quote from AIDS crisis:"During the darkest days of the AIDS crisis, we buried our friends in the morning, we protested in the afternoon, and we danced all night. The dance kept us in the fight because it was the dance that we were fighting for. It didn't look like we were going to win then, and we did. It doesn't feel like we're going to win now, but we could. Keep fighting. Keep dancing." - Dan SavagePodcast Episode guide and full show notes: https://bit.ly/WellShitEpisodeGuideFind our website and connect with us on Social Media: https://linktr.ee/theuniversalneeds Hosted on Acast. See acast.com/privacy for more information.

TEMPO DE REFLETIR 01697 – 8 de março de 2026 Ezequiel 28:15 – Perfeito eras nos teus caminhos, desde o dia em que foste criado até que se achou iniquidade em ti. Uma maçã podre numa caixa estraga todas as outras. Mas quando Deus criou o mundo, tudo era perfeito. Não havia germes nocivos, morte ou lágrimas. Infelizmente, nesse mundo perfeito apareceu uma maçã podre que estragou a criação de Deus. E a pergunta que surge é a seguinte: Se Deus é bom e todo-poderoso, por que não pegou essa maçã e a jogou no lixo, para evitar que ela estragasse as outras? Você não faria isso? Obviamente, estamos falando de Satanás. Deus sabia que se Satanás continuasse vivendo, sua influência perniciosa se espalharia pela terra e resultaria em Hitler, Idi Amin, Stalin, Saddam Hussein e outros tiranos. Resultaria também em males como o câncer, AIDS, depressão, solidão, defeitos congênitos, alcoolismo, dependência de drogas, acidentes, crimes e divórcios. Em resumo: resultaria num mundo cheio de miséria e dor. Foi justo da parte de Deus deixar que toda essa miséria se espalhasse quando poderia ter cortado o mal pela raiz? Vejamos a seguinte ilustração: Uma empresa tinha um diretor que era amado por seus gerentes e funcionários. O seu assistente o ajudava em tudo. Mas então esse assistente começou a espalhar o boato de que o diretor estava fraudando a empresa. Foi um golpe devastador num líder que sempre havia procurado ser honesto e leal. Pior ainda foi o fato de que entre os gerentes e funcionários houve quem acreditasse no boato. O assistente havia preparado o terreno e conquistado simpatizantes. E quando ele fez essa denúncia, muitos acreditaram nele. Alguns até sugeriram que o conselho dos diretores deveria colocá-lo no lugar do diretor. O diretor poderia tê-lo despedido. Mas pensou: “Mesmo os funcionários que confiam em mim podem desconfiar que eu tenha algo a esconder, pois demito quem discorda de mim. E funcionários que não confiam em seu líder, trabalham mal”. Assim, o diretor permitiu que o seu assistente continuasse trabalhando. Mais cedo ou mais tarde a verdade apareceria. E foi o que aconteceu. A empresa passou por um período difícil, todos perceberam que a acusação do assistente era falsa, e ele acabou pedindo demissão. Tal e qual aquele presidente, Deus deu a Satanás tempo para que surgissem os frutos de sua obra. E ao derramar “o sangue do Filho de Deus, desarraigou-se Satanás das simpatias dos seres celestiais” (O Desejado de Todas as Nações, p. 761). No seu devido tempo a maçã podre será, finalmente, jogada fora. Reflita sobre isso no dia de hoje e ore comigo agora: Ajuda-me, Pai, a confiar inteiramente em Ti. Que nunca a semente da dúvida ganhe espaço para crescer em minha mente e coração. Por favor, em nome de Jesus, amém! Saiba como receber as mensagens diárias do Tempo de Refletir: -> No celular, instale o aplicativo MANAH. -> Para ver/ouvir no YouTube, inscreva-se neste Canal: youtube.com/AmiltonMenezes7 -> Tenha os nossos aplicativos em seu celular: https://www.wgospel.com/aplicativos -> Para receber pelo WhatsApp, adicione 41 99893-2056 e mande um recadinho pedindo os áudios. -> Participe do nosso canal no TELEGRAM: TELEGRAM AMILTON MENEZES . -> Participe do nosso canal no WhatsApp: WHATSAPP CHANNEL Amilton Menezes . -> Instagram: https://www.instagram.com/amiltonmenezes7/ -> Threads: https://www.threads.net/@amiltonmenezes7 -> X (Antigo Twitter): https://x.com/AmiltonMenezes -> Facebook: facebook.com/AmiltonMenezes

President Trump stands firm on his hard line approach with Tehran, an American adversary is apparently aiding Iran's fight against the U.S., and an age old conflict breaks anew between the CEOs of Mcdonalds and Burger King. Get the facts first with Evening Wire. - - - Ep. 2668 - - - Wake up with new Morning Wire merch: https://bit.ly/4lIubt3  - - - Today's Sponsor: Lean - Get 20% off when you enter code WIRE at https://TakeLean.com - - - Privacy Policy:⁠ ⁠https://www.dailywire.com/privacy⁠⁠ morning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join Dr. Martin in today's episode of The Doctor Is In Podcast.  

This week, we're jetting off to Eswatini! Highlights include: - It used to be Swaziland, don't you know... - Everyone knows there's half as many flags as countries, right? - Can we make a game about AIDS and low life expectancy? - Watch out for lightning! - Eddie Redmayne, and some woman... - Obviously, all game artists know each other... - Save the rhinos!

The People of Color Against AIDS Network (POCAAN), a pivotal health service provider in the Pacific Northwest, has announced the appointment of Ernest Walker as its new executive director. A Seattle native and University of Washington alumnus, Walker brings extensive community ties and national nonprofit leadership experience to the position. Established in 1987 in response to the AIDS epidemic, POCAAN has evolved to play a crucial role in promoting health equity and delivering culturally responsive care to communities of color across the region. Interview by Chris B. Bennett.

An unassuming house in Southeast Portland’s Buckman neighborhood was recently added to the National Register of Historic Places. Once known as “Juniper House,” the building served as one of the first end-of-life care homes for AIDS patients in the Pacific Northwest in the late 1980s. An OPB documentary at the time explored the lives of some of the patients in Juniper House and the neighboring Assisi House, which provided a range of care for patients with HIV/AIDS. Jan Weyeneth is one of the co-founders of Juniper House. Cayla McGrail is a former associate project manager for Portland’s LGBTQ+ Historic Sites Project, which sponsored the house’s listing. We first spoke with Weyeneth and McGrail in April 2025 about Juniper House and the importance of documenting queer history in Portland.

You asked, you waited, and he's finally here — our most requested guest: Bob. Yes, that Bob. The man behind the now-iconic line, “Bob, get the wig!” and the brave soul who married Walnut Grove's most notorious troublemaker, Nellie Oleson — known to the world, of course, as our Prairie Bitch, Alison.In this heartfelt (and very funny) episode, Bob shares the sweet and surprisingly down-to-earth story of how he and Alison met and fell in love. Spoiler: real life involves far fewer tantrums and significantly fewer ringlets.We also talk about Bob's meaningful work with the AIDS Project Los Angeles helpline during the height of the AIDS crisis — a moving chapter that shaped his life and reflects the compassion at the core of their partnership.And yes, we get into the moment his family and friends found out he was marrying the woman who once terrorized Laura Ingalls on national television. The reactions? Let's just say there may have been some pearl-clutching.It's an episode full of humor, heart, and the reminder that behind every great Prairie “villain” is a very patient, very lovely husband. And Bob — thanks for getting the wig.Then join us on Patreon, where Pamela, Alison, and Dean share stories about their significant others and how they support us as crazy artists. It's fun, funny, very personal, and heartfelt.Links and Resources:Haven't signed up for Patreon yet? Get more behind-the-scenes info and fun conversation we can't do on the podcast...PATREON: https://www.patreon.com/LittleHousePodcastwww.LittleHouse50Podcast.com to connect with our hosts and link to their websites.www.LivinOnaPrairieTV.com  Check out the award-winning series created by Pamela Bob, with special guest stars Alison Arngrim and Charlotte Stewart.Prairie Legacy Productions - the place to go for info about all new Little House events!To learn more about Little House on the Prairie, Visit www.littlehouseontheprairie.comFacebook/Instagram/TikTok:Dean Butler @officialdeanbutlerAlison Arngrim @alisonarngrimPamela Bob @thepamelabob, @prairietvSocial Media Team: Joy Correa and Christine Nunez https://www.paclanticcreative.com/Producer: Tony Sweetwww.ubngo.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/little-house-on-the-prairie-50th-anniversary-podcast--6055242/support.

“ Barney and I were interviewed about that episode on Entertainment Tonight because the word “condom” had never been used on television before.” - Georgia Jeffries, Cagney & Lacey writerHosts Susan Lambert Hatem and Sharon Johnson welcome writer-producer-professor Georgia Jeffries, an Award-winning writer known for Cagney & Lacey, China Beach, and Sisters. Jeffries recounts growing up as an only child, loving The Twilight Zone, reading history, and finding an early spark for writing through school assignments and UCLA journalism and creative writing courses.She talks about her time working as a freelance journalist while caring for her family. And the pivotal LAPD ride-along that inspired her first produced Cagney & Lacey episode, “An Unusual Occurrence,” which won a WGA Award. She compares the culture of Cagney & Lacey with China Beach, discusses unproduced pilots and projects (including HBO series, and an unmade Cher/Jessica Lange/to-be-directed by Frank Oz movie, Confessions) She reflects on writing episodes that tackled addiction, AIDS-era conversations, and sexual assault. Jeffries also shares details about her novel, The Younger Girl, current writing projects, and advice to emerging writers.00:00 Welcome and Guest Intro01:33 Childhood TV Influences03:56 Good Girl Expectations05:16 Finding Writing Path07:48 Early Jobs and Teaching10:43 LAPD Ride Along Story14:34 Cagney and Lacey Breakthrough16:09 Feminism and California Move18:09 Film Journalism to Screenwriting19:34 Unmade Cher Lange Film24:16 Women in Film Opens Doors29:47 HBO Script to Book Rights34:54 Working Mother on Set36:14 Writers Room Culture Then39:55 Favorite Episodes Tease40:09 Why This Story Matters40:47 Writing Cagney and Lacey44:28 TV Breaking Taboos46:45 Breaking Into Screenwriting48:17 Saying Yes and No49:11 Joy and Rejection51:11 Unmade Pilots Heartbreak52:55 China Beach Bigger Canvas55:55 Writers Room Culture57:50 Showrunner Dream Team58:39 Vista Clara and Timing01:00:31 Teaching at USC01:01:07 Resist AI Stay Original01:02:00 You Write Like a Man01:04:33 Working on Sisters01:06:27 The Younger Girl Novel01:14:36 Prose Versus Screenwriting01:16:49 New Work and Wrap Up01:19:11 Where to Find Everything01:21:58 Final Thanks and CalloutsAUDIOOGRAPHYFind out more about Georgia Jeffries at georgiajeffries.comGet Georgia's book, The Younger Girl at Bookshop.orgFind out more about the groundbreaking and Emmy-winning show at CagneyandLacey.comCall your Reps. Let your voice be heard. Go to 5calls.orgWatch on Roku for Sisters and China Beach. PROMO DEALSGet awesome sheets and pajamas at COZY EARTH.Be sure to use the promo code: 80STVLADIES.Happy Shopping!MARCH 8TL DEALS BLOCK:80s TV Ladies deals and discounts:Cozy Earth (21% Off)

This week on No Script, Jackson and Jacob (finally) discuss a play by Terrence McNally. "Mothers and Sons" is a small, intimate play about two people meeting nearly two decades after they both lost someone close to them. The play also tracks how the world has changed since the AIDS crisis. Listen in!  ------------------------------ Please consider supporting us on Patreon. For as low as $1/month, you can help to ensure the No Script Podcast can continue.  https://www.patreon.com/noscriptpodcast  ----------------------------- We want to keep the conversation going! Have you read this play? Have you seen it? Comment and tell us your favorite themes, characters, plot points, etc. Did we get something wrong? Let us know. We'd love to hear from you. Find us on social media at:  Email: noscriptpodcast@gmail.com Facebook: https://www.facebook.com/No-Script-The-Podcast-1675491925872541/ Instagram: https://www.instagram.com/noscriptpodcast/ Twitter: https://twitter.com/noscriptpodcast/ ------------------------------ Thanks so much for listening! We'll see you next week.

Heather and Jonny commiserate over the eruption og globala military actions and the controversyies around the Trump Administrations actions and (lack of) explanations. They posit the role of conflict in controling and manipulating others. They then take this theme of x vs. y to other conflicts recently impacting the LGBTQ+ community, some further illuminating the US vs. Iran conflict eclipsing all others at the moment.

Six years after the World Health Organization declared Covid-19 a global emergency, are we any better prepared for the next pandemic? Professor Joseph Harris reflects on what Covid revealed about the strengths and weaknesses of the U.S. public health system and the fragility of global cooperation. Drawing on his research on universal health coverage and AIDS treatment politics in countries such as Thailand and Brazil, he explains how politics and power shape who has access to care—and how professional and social movements can drive reform. For more on this topic: Listen to Harris's podcast: The Global Health Politics Podcast Check out his commentary in The Conversation: What the US could learn from Thailand about health care coverage

Ilana Landsberg-Lewis went to law school to understand how power works—so she could help transform it in the service of justice, especially for women. Alongside her father, she co-founded and led a nonprofit funding community-based organization in sub-Saharan Africa working to turn the tide of AIDS and support African grandmothers raising a generation of grandchildren orphaned by the pandemic. When others dismissed older women as “not a sustainable investment,” Ilana helped launch an international movement of grandmothers across Canada, the UK, and the United States—raising more than $50 million and supporting millions of grandchildren. At the center of this work is her unwavering belief that older women are not only caregivers, but leaders, change-makers, and moral anchors for their communities.Through her podcast and fund, Ilana lifts up older women's stories and their power-- a practice of love and a commitment to liberation—from the chains of inequality and from the limits placed on whose lives are valued. Her work invites us to see the human family more fully, and to recognize older women as essential architects of justice across the globe.Connect with IlanaEmail:grandmothersonthemove@gmail.comWebsite: wisdomatworkpodcast.comThank you to our SPONSOR—AARP Illinois, dedicated to empowering adults 50 and older to choose how they live as they age. AARP Illinois advocates for the health, financial security, and overall well-being of Illinois residents through community programs, expert resources, and member benefits. aarpil@aarp.orgRecognizing the Age-Wise Collective. Women Over 70-Aging Reimagined has joined other women podcasters to amplify the voices of women over 50. We shine the light on gerontologist Sally Duplantier, founder and host of My Zing Life, dedicated to helping older adults live their best lives longer. Her current Healthspan work focuses on improving health behaviors and mental well-being for vulnerable populations through community-based health coaching. https://sally@myzinglife.com

Holy Shed Presents | Winnie the Pooh (and other hermeneutical aids) Welcome back to the littlest parish in the whole of Christendom. Join me for more chat and insights about my way of reading and interpreting parts of the bible and the world we live in. Follow Holy Shed on Facebook; https://www.facebook.com/theholyshed/ Support Holy Shed on Ko-fi; https://ko-fi.com/holyshed follow Dave on https://facebook.com/dave.tomlinson.925/ follow Dave on https://instagram.com/bad_christian/Go

This episode explores how sustained scientific ambition, backed by flexible philanthropy, has helped transform HIV from a fatal diagnosis into a manageable condition and why the search for a cure remains both urgent and achievable. At the centre of the conversation is the work of amfAR and its distinctive role in advancing research that changes lives far beyond a single disease area. Founded in the mid-1980s, at a time when HIV and AIDS were poorly understood and highly stigmatised, the organisation emerged from the determination of clinicians, researchers and advocates who refused to wait for slow-moving systems to respond. From the outset, the mission was clear: fund innovative research quickly, support bold ideas early, and accelerate scientific discovery where it was needed most. Since its first grants in 1985, the organisation has invested nearly one billion dollars in research and supported more than 3,900 researchers across the world. Rather than simply awarding grants, its approach has been to invest in people and ideas, often at the earliest and riskiest stages. Many of those early investments have gone on to underpin treatments now used globally, including antiretroviral therapies that allow people living with HIV to lead long, healthy lives. The episode places this progress in today's global context. More than 40 million people worldwide are living with HIV, with around 1.3 million new infections each year. While treatment has transformed outcomes in many countries, access remains deeply unequal. Women and girls account for over half of those living with HIV globally, and people in low-income and marginalised communities, particularly in sub-Saharan Africa, continue to face life-threatening barriers to care. Against this backdrop, the case for a cure remains compelling. Lifelong treatment depends on stable health systems, consistent access and freedom from stigma, conditions that are far from guaranteed. A cure would remove these structural vulnerabilities. Importantly, the science now points to possibility. Around ten individuals have been effectively cured of HIV, providing researchers with vital clues and a credible roadmap. Current cure-focused research is tackling some of the most complex questions in virology. This includes understanding latent viral reservoirs, where HIV hides in the body, and finding ways to reactivate and eliminate the virus. Researchers are also studying elite controllers, people whose immune systems suppress HIV without medication, to uncover mechanisms that could inform new treatments. Alongside this, insights from cancer, ageing, autoimmune disease and other viral infections are increasingly shaping HIV research, highlighting the interconnected nature of scientific discovery. A key theme running through the conversation is what defines a viable cure. It must be scalable, affordable and easy to administer, not a solution that only works in specialist settings. This emphasis on real-world applicability shapes funding decisions and research priorities. The funding model itself is central to this work. Research is supported entirely through private philanthropy, from individual donors and family foundations to global fundraising events. Independence allows decisions to be driven by science rather than politics, while short funding timelines enable researchers to move quickly. Rigorous peer review ensures standards remain as high as those of major public institutions, without the inertia that can stifle innovation. Beyond HIV, the episode highlights how this model has influenced advances in other fields. Research originally funded to understand HIV has contributed to breakthroughs in cancer immunotherapy and vaccine development, including technologies later used in mRNA vaccines. Today, the organisation is expanding its focus to areas such as cancer, Alzheimer's disease, immunotherapy and artificial intelligence, particularly where these intersect with the needs of an ageing HIV-positive population. Woven throughout the discussion is the human impact of research. Funding science does more than produce data and treatments; it provides hope. Knowing that researchers are actively working towards a cure can fundamentally change how people live with a diagnosis. Investment in early-stage research becomes an investment in dignity, longevity and possibility. The episode closes with a clear message. Scientific discovery is not confined to governments or large institutions. Individuals and philanthropists can play a decisive role in advancing research that affects every household. Supporting bold ideas early is one of the most powerful ways to accelerate global health progress and, ultimately, to help make AIDS history. Visit our Knowledge Hub at Lidji.org for information on 350+ case studies and interviews with remarkable leaders in philanthropy, sustainability and social entrepreneurship. 

We are back at it this week, discussing the recent BAFTA awards controversy, and we all learn what BAFTA means. Jim Carrey or someone who looked almost like him accepted an award this week, so celebrity clones are all the rage. The Cherry on top of this episode is Shia LaBeouf's recent Mardi Gras mix-up. Next time you're maxin' and relaxin' on the john, make sure to subscribe to our YouTube, and like and follow us on all of our socials!

During our continued news hour on NightSide, we discussed a new report from Congress that has raised the alarm about children with mental health conditions being held in juvenile detention, rather than getting treatment…8:05PM: A new report from Congress has raised the alarm about children with mental health conditions being held in juvenile detention, rather than getting treatment…A discussion about the lack of mental health services for children.Guest: Tim Murphy, PhD - licensed psychologist8:15PM: Discovering King Tut’s Tomb, a comprehensive show about the monumental discovery of the celebrated Egyptian Boy King, opens on February 28 at the Saunders Castle at Park Plaza.Guest: Mark Lach - expert spokesperson for the exhibition of Discovering King Tut’s Tomb 8:30PM: Addressing the virulent anti-Semitism that has bizarrely found a home at Harvard and MIT…Guest: David Nabhan (pronounced how it sounds Nab – Han) - science columnist for the Times of Israel 8:45PM: Shooting Up: A Memoir of Love, Loss and Addiction. The child of missionary parents thrusted into Madrid, Spain’s San Blas neighborhood tells the story of a unique childhood among heroin addicts during the AIDS epidemic. A haunting exploration of belief, belonging, and the profound costs—and rewards—of sacrifice.Guest: Jonathan Tepper – Author of this book. Grew up in Madrid in the 1980s, and his parents started a drug rehab among heroin addicts. – He is currently the chief investment officer at Prevatt CapitalSee omnystudio.com/listener for privacy information.

In episode 70 of Going anti-Viral, Peter Staley joins host Dr Michael Saag after giving the Martin Delaney presentation at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled ''Annus Horribilis" and The War on Science: Thoughts on Resisting and Rebuilding. Mr Staley shares his inspiring story as a pioneering HIV and LGBTQ+ rights activist, recounting his journey from the early days of the AIDS crisis to groundbreaking activism leading to a seat at the table with clinicians and researchers in bringing life-saving treatments to people with HIV and AIDS. Dr Saag and Mr Staley also reflect on the recent era of anti-science activism during the COVID-19 pandemic and share their advice for young researchers who may be the generation of scientists that bring about a cure for HIV.0:00 – Introduction 2:30 – The early days of AIDS awareness6:23 – Peter's reflections on his positive HIV test result10:46 – Transitioning from Wall Street to activism12:11 – The formation ACT UP and impact of Larry Kramer15:22 – Channeling anger into activism17:47 – Targeting the FDA and the fight for drug access20:26 – The role of the NIH and Tony Fauci 24:10 – The Parallel Track: access to experimental drugs25:40 – The role of the Treatment Action Group (TAG) and the AIDS Clinical Trials Group (ACTG)26:32 – The breakthrough: viral load and undetectable levels31:18 – Reflections on COVID-19: activism in a new era33:45 – Prep4All: advocating for access to PrEP38:38 – Advice for young clinicians and closing remarksResources:Watch Peter Staley's presentation at CROI 2026 ''Annus Horribilis" and The War on Science: Thoughts on Resisting and Rebuilding YouTube:  https://youtu.be/p5kqUujWPCs PrEP4All: https://prep4all.org/ CROI 2026: https://www.croiconference.org/ __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Matthew Bannister onMartyn Butler who was a central figure in the UK's early response to HIV and AIDS. He was a co-founder of the Terrence Higgins Trust and gave his own home phone number as a helpline.Allan Massie, the Scottish author and critic whose hero was Sir Walter Scott. Sir Ian Rankin pays tribute. Professor Nicola Fear, the epidemiologist who studied the effects on military personnel of serving in the Iraq War and Afghanistan.Willie Colón, the American trombonist who was inspired by his Puerto Rican heritage to create salsa music.Interviewee: Tony Whitehead Interviewee: Sir Ian Rankin Interviewee: Professor Sir Simon Wessely Interviewee: Garth CartwrightProducer: Gareth Nelson-Davies Assistant Producer: Ribika Moktan Editor: Glyn TansleyArchive used: Martyn Butler seminar recording, Terrence Higgins Trust, THT YouTube channel, uploaded 26/06/2022; Terrence Higgins Trust actuality recording, Week In Week Out, BBC Wales, 29/10/1985; News report, BBC News, 08/01/1987; Advert: Iceberg, Department of Health and Social Security, Dir Nicolas Roeg, Voiceover: John Hurt, 1987; Allan Massie, The Book Programme: First Novels, BBC Two, 11/02/1978; Allan Massie interview, France Politics, Writers Revealed, BBC Radio 4, 06/07/1992; Allan Massie interview, General Election Report, BBC News, 10/04/1997; Nicola Fear, The Fear Factor: life as a military epidemiologist, King's College London, uploaded to YouTube on 23/04/2018; Iraq War news report, BBC News, 31/03/2009; Afghanistan News Report, BBC News, 27/10/2014; Willie Colon interview, Latin Music USA, BBC Four, 05/02/2010;

In this episode of Infinite Loops, we sit down with author Jonathan Tepper to discuss his extraordinary childhood. In 1985, when Jonathan was seven, his missionary parents moved the family to San Blas — then the heroin capital of Europe — to start a drug rehabilitation center. Jonathan and his brothers grew up alongside former bank robbers, prison survivors, and people living through the AIDS epidemic. These recovering addicts became like older siblings to them. What began with one man in a small apartment grew into a global movement operating in 20 countries. Jonathan's memoir, Shooting Up: A Memoir of Love, Loss, and Addiction, is out now and published in the US by Infinite Books and in the UK by Little, Brown Book Group. Important Links Buy Shooting Up: A Memoir of Love, Loss and Addiction: https://www.infinitebooks.com/books/products/shooting-up Read the first chapter for free: https://infiniteloops.substack.com/p/give-them-to-anyone-who-looks-like Learn more about Jonathan here: https://jonathan-tepper.com/

In this episode of Money Tales, our guest is Stephanie Ellis-Smith. Marriage caused Stephanie to face two hard truths at once. The medical career she had poured herself into did not fit the life she wanted to build with her husband. And perhaps even more unsettling, a career in medicine was not clicking the way she had always assumed it would. When she stepped away, Stephanie felt like she was walking out on an identity her family had invested everything in. Her dad even told her, quite bluntly, that she had no employable skills. Then, in the middle of that uncertainty, Stephanie said yes to a small volunteer opportunity. That single yes ended up rerouting her life into a decades long career in philanthropy, including founding three nonprofits and Phila Engaged Giving. Stephanie is the CEO and founder of Phīla Engaged Giving, a philanthropic advisory firm established in 2017 that works with donors who are ready to activate their assets for social change. As an advisor and social impact specialist, she works toward a world where philanthropy is a nurturing and equity-centered practice that connects wealth to the people and communities who need it most. Stephanie is a Chartered Advisor in Philanthropy (CAP®) with extensive experience in advising high-impact individuals and companies. She believes strongly in being a compassionate and generous member of society and brings nearly 30 years of professional and personal life experience in governance, family wealth and nonprofit leadership to the social sector. In the wake of the racial uprisings of 2020, she co-founded Giving Gap, an online database to help donors find and support Black-founded and led organizations in their communities. Having served in a variety of professional capacities—non-profit CEO, social enterprise COO, foundation and non-profit trustee and corporate board member—Stephanie's extensive background and deep knowledge makes her uniquely well-positioned to be a trusted advisor to the world's most generous families and institutions. Stephanie's expertise in navigating wealth, impactful generosity and civic engagement is frequently sought by leading philanthropic institutions and mainstream publications and she has frequently appeared as a keynote speaker at major social sector convenings. Several Seattle mayors and former Washington Governor Gary Locke have appointed Stephanie to serve on a variety of boards and public commissions. She is currently a member of the Seattle Art Museum's Museum Development Authority Board and the board of the National Center for Family Philanthropy. She was appointed a Dean of Philanthropy in 2022 by The Purposeful Planning Institute. Stephanie has BA degrees from UCLA in both English Literature and Biochemistry. Given her keen interest in science, Stephanie's post-graduate years were spent in university labs working on stem cell and AIDS-related research. She has two adult children and lives in Seattle with her husband, the historian Douglas Smith. Finding Purpose Through Philanthropy Stephanie's journey shows that philanthropy is far more than writing checks or serving on boards. It is a deeply human practice that shapes relationships, careers and how we understand money, power and purpose. From her own career pivot to the way she helps families navigate charitable giving, her story illustrates how generosity can change the giver as much as the causes they support. By speaking openly about her own money story, identity and career reinvention, she reminds listeners that meaningful giving begins with honest conversations and a willingness to learn. If you are thinking about how to align your wealth with your values, an Aspiriant advisor can help you clarify your purpose, structure your giving and build a thoughtful philanthropic plan that fits your family. Follow Money Tales on Spotify, Apple Podcasts or YouTube Music for more real stories that help us make smarter, more intentional decisions with our money.

Dr. Cary L. Goodman has a sincere passion to empower faith communities to operate at their fullest capacity in areas of health promotion, advocacy programs, outreach and development. For over 18 years, he has been dedicated to establishing and expanding health programs across the United States by building the capacity to address health disparities that greatly impact congregations and the communities they serve by strategically leveraging faith-based and community partnership to impact sustainability. Currently, Cary serves as the Faith Based Program & Engagement Consultant for The Balm In Gilead, Inc. where he works diligently at the intersection of faith and public health nationally to address the burden of various diseases the impact African American communities. A highly skilled strategist and national speaker adept at leading relationship building and engagement opportunities, he has forged various faith based and public health community partnerships and coalitions. An ordained minister, Cary deems himself a “connector” where he focuses on the significance of outreach and engagement, establishing coalitions, collaborating, and relationship building in order to increase accessibility and sustainability to strengthen congregations and communities.

Africa Melane chats to SANAC’s Nelson Dlamini about treasury allocating R26bn to provinces to sustain HIV/AIDS treatment. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Send a FanMail to the GenX Stories gang via text message!It's time. The Gen X Stories crew gets brutally honest about growing up in the shadow of AIDS panic, whispering about Dr Ruth after dark, and parents who absolutely did not have “The Talk” with us. We dig into how we pieced together our own sex education through rumors, paperbacks, health class scare tactics, and sheer survival,. You may recognize the funny (and sometimes unpleasant) experiences that followed, and why buying condoms felt like applying for federal clearance. PLUS we are open about flipping the script on how we're talking about sex with our own kids now. (Spoiler: less fear, more facts.) It's awkward. It's cathartic. It might make you text your therapist. But hey — at least we can finally talk about it. (although maybe not with our moms...)Episode linksWhy the Sex Talk with Kids Is a Myth (And What Works Better)History of Sex Education in the USHow AIDS Changed the History of Sex EducationThe History Behind Judy Blume's Most Controversial Novel, ForeverWhen Dr. Ruth Doled Out ‘80s-Era Sex AdviceRisky Busness Movie Train Scene“Where Did I Come From?” book“What's Happening to me?” book- Girls edition“What's Happening to me?” book- Boys edition“This is so awkwzrd: modern puberty explained” bookConnect with usSubscribe to GenX St

In this episode, produced in partnership with RahrBSG, we're taking a close look at process aids in the brewhouse and cellar, from anti-foaming agents and finings to enzymes and more. Whether you're trying to keep more foam in your beer (rather than lose it while brewing and cellaring), fill tanks with more beer and less headspace (by limiting foam height within tanks), or clarify beer while reducing filtering time and expense (by using finings), there's a process aid that fits your goal. Here, we discuss the ins and outs of using these tools effectively in the brewery with Sam Pecoraro of Von Ebert in Portland, Oregon; Steve Theoharides of Zero Gravity in Burlington, Vermont; and Ashton Lewis, technical support manager at RahrBSG. We produced this episode in partnership with RahrBSG, your leading source for brewing ingredients and supplies. To learn more about the solutions RahrBSG offers, visit their site and contact your representative today.

Stephen Shames – A Legendary Documentary Photographer (Part 2)

People often take the easy path, but what can you achieve and grow by jumping into thorny problems that don't have an obvious solution?Today's guest on Contrary to Ordinary is Dr. Alex Vieira. He's a pioneer in cleft-palate research, has authored more than 400 scientific papers, and is the most cited expert in the field.In this episode, Alex shares his journey from growing up in Rio de Janeiro during the military regime to becoming a leading figure in oral health research. He discusses his decision to pursue dentistry, influenced by an admired uncle, the challenges of starting his research career during the AIDS epidemic, and his fascination with the Human Genome Project.In this episode's commentary, Kim discusses the importance of the entrepreneurial mindset and the roles of genetics and environment in shaping human behavior. He emphasizes the value of collaboration, the importance of local contributions to global impact, and the need to maintain high research standards. Overall, Alex believes in following one's passion and making meaningful changes in the immediate environment, which he sees as having a trickle-down effect on broader societal improvements.Episode Highlights01:49 –Alex's early life.04:41 – How working with genetics changed the trajectory of Alex's career.08:00 – Kim's thoughts: Surround yourself with those you admire - the rest will follow.08:46 – The Human Genome Project and dentistry.12:10 – The road less travelled and the genetics of extraordinary.14:47 –Kim's thoughts: Can you change your genetic predisposition through forming new habits?15:55 – The complicated world of genetics and dental caries.19:49 – What drives Alex?20:41 – Kim's thoughts: The entrepreneurial mindset isn't just for business people.23:43 –How does Alex maintain a high standard of work?24:47 – What's next for Alex?25:56 – Alex's final thoughts.ResourcesFollow your curiosity, connect, and join our ever-growing community of extraordinary minds.CariFree WebsiteCariFree on InstagramCariFree on FacebookCariFree on PinterestDr. Alex Vieira BioThe Human Genome Project WebsiteThe Power of Habit - Charles DuhiggAtomic Habits: An Easy & Proven Way to Build Good Habits & Break Bad Ones - James Clear

Gregory Zuckerman introduces the brilliant, driven scientists pursuing vaccines for AIDS, cancer, and malaria, who pivoted their controversial methodologies to confront the burgeoning COVID-19 pandemic. 3

To Find All Things StrangeBrew!---> linktr.ee/strangebrewpodcastSign up for our Patreon go to-> Patreon.com/cultofconspiracypodcastMeta Mysteries Podcast---> https://open.spotify.com/show/6IshwF6qc2iuqz3WTPz9Wv?si=3a32c8f730b34e79Cajun Knight Youtube Channel---> https://www.youtube.com/@Cajunknighthttps://flavorsforest.com/cult/Become a supporter of this podcast: https://www.spreaker.com/podcast/cult-of-conspiracy--5700337/support.

Show Notes: Rick Thomas interviews Jonathan Tepper, the author of Shooting Up: A Memoir of Love, Loss, and Addiction, a coming-of-age memoir set in Madrid's San Blas neighborhood during Spain's heroin and AIDS crisis. Raised by missionary parents who founded a drug rehabilitation center at the height of the epidemic, Tepper tells a gritty, lyrical story of addiction, recovery, faith, and loss, as seen through the eyes of an American boy growing up in the middle of it. Watch or Listen: https://lifeovercoffee.com/podcast/ep-568-jonathan-tepper-shooting-up-a-memoir-of-love-loss-and-addiction/ Will you help us to continue providing free content for everyone? You can become a supporting member here https://lifeovercoffee.com/join/, or you can make a one-time or recurring donation here https://lifeovercoffee.com/donate/.

GS#488 May 12, 2015  Martin Chuck, the inventor of the hugely successful Tour Striker returns to showcase his newest products and actually convinces host Fred Greene that there are training aids that can be as valuable as lessons and a lot more cost effective! Martin gives a full description of his hot new "Smart Ball" which assists in avoiding the chicken wing that makes your back arm fly out on the backswing. Martin is actually surpirsed and flattered to find out that it's being used by players on the PGA Tour,. We also discuss his two latest inventions and recap his hugely successful Tour Striker. Martin's closing tip explains why you slice the ball and how to fix it. This tip is also a video available at http://YouTube.com/GolfSmarterTV http://TourStriker.comIf you have a question about whether or not Fred is using any of the methods, equipment or apps we've discussed, or if you'd like to share a comment about what you've heard in this or any other episode, please write because Fred will get back to you. Either write to golfsmarterpodcast@gmail.com or click on the Hey Fred button, at golfsmarter.com

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

It took years for U.S. leaders to address the AIDS epidemic of the 1980s. One public figure that wasn't afraid to bring the challenges the LGBTQ+ community were facing to the forefront was the Rev. Jesse Jackson. In the Loop reflects on Jackson's work pushing progressive ideas and being an avid supporter of the LGBTQ+ community with Northwestern professor Martha Biondi and Equality Illinois CEO Channyn Lynne Parker. For a full archive of In the Loop interviews, head over to wbez.org/intheloop.

David Zellnik tells Kevin Allison about a moment of sexual liberation in a dark back room at a gay bar in the early 90s. Check out all of our Conversation Stories!

SEASON 4 EPISODE 59: COUNTDOWN WITH KEITH OLBERMANN A-Block (2:30) SPECIAL COMMENT: Just because we're paranoid, that doesn't mean Trump isn't out to get us. Trump has just accidentally revealed crucial details of his conspiracy to steal the midterms. It starts with the cadaver-in-chief, demanding of active troops at Fort Bragg – “you have to vote for us” – that’s in case the Generals or even the Joint Chiefs realize Mark Kelly is right: they HAVE to disobey illegal orders, ESPECIALLY Trump’s illegal orders. If it came to that, Trump would have the raw troops overthrow the generals And then Trump succubus Kristi Noem vowed to make sure Trump only lets the RIGHT people voting, electing the RIGHT leaders. And he’s already had ICE PRACTICE voter suppression – murder of civilians – in Minnesota. How do we stop Trump? Talk about it endlessly. Talk about his attempt to make the troops loyal to HIM and not the constitution. Talk about his attempts to seize ballots. Talk about his attempt to use ICE to intimidate voters. Talk about it, now, now, now. Trump is plotting to steal the midterms. We not only CAN stop him - we have to. MEANWHILE, HOW MUCH MORE CAN THE MEDIA BETRAY US? Jake Tapper - as guilty as anybody in the business of putting his salary ahead of all journalism - tells us to hang in there? An old boss of mine says something stupid. CBS decides to platform Stephen A. Smith, the Jill Stein of 2026. B-Block (55:00) THE WORST PERSONS IN THE WORLD: What happened to Congressman Randy Fine demanding the arrest of everybody who enjoyed Bad Bunny's Swear-filled Super Bowl Show? The White House doesn't know how to spell "cue." And enjoying the Olympics? It's all crap - especially what it did to the history of the Olympics and the National Hockey League. C-Block (1:25:00) THINGS I PROMISED NOT TO TELL: More media criticism. This disaster didn't start yesterday. By 2004, when an anchor on MSNBC told one of his viewers - live on the air - to "get AIDS and die" - and his boss said he had to be fired for that, his boss's boss (THE PRESIDENT OF NBC) tried to intervene to save his job. See omnystudio.com/listener for privacy information.

Guest: Patrick K. O'Donnell. A failed Union raid on Richmond carrying orders to kill Jefferson Davis prompts the Confederacy to escalate irregular warfare and political influence operations. As the Confederate Secret Service aids the Copperhead movement, author Herman Melville embeds with Union cavalry to witness the hunt for the elusive John Mosby1880 GAR PICNIC MN